Puma Biotechnology Inc.

NASDAQ: PBYI · Real-Time Price · USD
5.68
0.36 (6.77%)
At close: Aug 15, 2025, 3:07 PM

Puma Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
69.22M 84.58M 76.2M 63.1M
Short-Term Investments
31.75M 11.35M 4.87M 18.98M
Long-Term Investments
n/a 2.09M 2.59M 3.31M
Other Long-Term Assets
2.38M 2.73M 4.66M 4.67M
Receivables
32.01M 48.49M 40.35M 32.53M
Inventory
8.72M 7.08M 4.53M 7.11M
Other Current Assets
3.7M 260K 3.87M 11.43M
Total Current Assets
147.66M 156.19M 134.28M 140.02M
Property-Plant & Equipment
5.09M 8.65M 12.51M 15.77M
Goodwill & Intangibles
51.13M 60.87M 70.61M 66.13M
Total Long-Term Assets
65.67M 74.34M 87.78M 86.56M
Total Assets
213.33M 230.53M 222.06M 226.59M
Account Payables
5.51M 6.89M 6.44M 11.17M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
50.87M 34M 4.14M 3.57M
Other Current Liabilities
34.19M 43.42M 50.8M 7.65M
Total Current Liabilities
96.11M 99.38M 77.48M 109.59M
Long-Term Debt
21.72M 65.66M 98.31M 97.09M
Other Long-Term Liabilities
1.88M 5.01M 12.83M 6.38M
Total Long-Term Liabilities
25.1M 77.7M 122.97M 119.44M
Total Liabilities
121.21M 177.09M 200.45M 229.03M
Total Debt
74.08M 111.49M 114.28M 116.64M
Common Stock
5K 5K 5K 4K
Retained Earnings
-1.31B -1.35B -1.37B -1.37B
Comprehensive Income
6K -4K n/a -2K
Shareholders Equity
92.13M 53.44M 21.6M -2.4M
Total Investments
31.75M 11.35M 4.87M 18.98M